Zobrazeno 1 - 10
of 81
pro vyhledávání: '"Alvaro Urbano-Ispizua"'
Autor:
Valentín Ortiz-Maldonado, Susana Rives, Marta Español-Rego, Anna Alonso-Saladrigues, Mercedes Montoro, Laura Magnano, Eva Giné, Mariona Pascal, Marina Díaz-Beyá, Maria Castella, Albert Català, Anna Faura, Luis Gerardo Rodríguez-Lobato, Aina Oliver-Caldes, Alexandra Martínez-Roca, Montserrat Rovira, E Azucena González-Navarro, Juan Ramón Ortega, Joan Cid, Miquel Lozano, Enric Garcia-Rey, Sara Fernández, Pedro Castro, Iolanda Jordan, Neus Villamor, Marta Aymerich, Montserrat Torrebadell, Àngela Deyà, Carlos Fernández de Larrea, Daniel Benitez-Ribas, Esteve Trias, Sara Varea, Gonzalo Calvo, Jordi Esteve, Alvaro Urbano-Ispizua, Manel Juan, Julio Delgado
Publikováno v:
Journal for Immunotherapy of Cancer
The prognosis of patients with relapsed/refractory (R/R) acute lymphoblastic leukemia (ALL) remains poor, particularly for those relapsing after allogeneic hema-topoietic cell transplantation (alloHCT). Novel agents such as inotuzumab ozogamicin or b
Autor:
Siddhartha Ganguly, Andrew Daly, Tracey A. O'Brien, Melhem Solh, Steven Z. Pavletic, Rammurti T. Kamble, Leslie Lehmann, Tao Wang, Takanori Teshima, Amer Beitinjaneh, Miguel Pérez, Mahmoud Aljurf, Mukta Arora, John L. Wagner, Medhat Askar, Marjolein van der Poel, Madan Jagasia, Rabi Hanna, Alvaro Urbano-Ispizua, Ravi Vij, Armin Rashidi, Taiga Nishihori, Catherine J. Lee, A. Samer Al-Homsi, Vijaya Raj Bhatt, Michael T. Hemmer, Roger Strair, Hannah Choe, Joseph Pidala, Jeffery J. Auletta, Hisham Abdel-Azim, Vaibhav Agrawal, Shahinaz M. Gadalla, Stefan O. Ciurea, S Spellman, Margaret L. MacMillan, Rodrigo Martino, Jean-Yves Cahn, Mitchell S. Cairo, Basem M. William, Rizwan Romee, Jean A. Yared, Navneet S. Majhail, Annie Im, Usama Gergis, Mohamed A. Kharfan-Dabaja, Richard F. Olsson, Sagar S. Patel, Baldeep Wirk, Peiman Hematti, Michael Byrne, Asad Bashey, Hemant S. Murthy, Betty K. Hamilton, Muna Qayed, Pooja Khandelwal, Robert Peter Gale, Saurabh Chhabra, Gerhard C. Hildebrandt, Jan Cerny, Sachiko Seo, Roger H. Herzig, Nosha Farhadfar, Deepesh Lad, Hélène Schoemans, Akshay Sharma, Tim Prestidge, Lazaros J. Lekakis, Daniel J. Weisdorf, Paul Castillo, Miguel-Angel Perales
Publikováno v:
Biol Blood Marrow Transplant
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
Biology of Blood and Marrow Transplantation, 26(8), 1459-1468. Elsevier Science
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
Biology of Blood and Marrow Transplantation, 26(8), 1459-1468. Elsevier Science
Post-transplant cyclophosphamide (PTCy) has significantly increased the successful use of haploidentical donors with a relatively low incidence of graft-versus-host disease (GVHD). Given its increasing use, we sought to determine risk factors for GVH
Autor:
Lawrence S. Lamb, Hemalatha G. Rangarajan, Ran Reshef, Rodrigo Martino, Mahmoud Aljurf, Parinda A. Mehta, Sachiko Seo, Aleksandr Lazaryan, Hisham Abdel-Azim, Miguel Angel Diaz, Vijaya Raj Bhatt, Jean-Yves Cahn, Olle Ringdén, Robert Peter Gale, Jean A. Yared, Shatha Farhan, Usama Gergis, Daniel R. Couriel, Sagar S. Patel, Peiman Hematti, Betty K. Hamilton, Paul Castillo, Mukta Arora, Bipin N. Savani, Lolie C. Yu, Muna Qayed, Leo F. Verdonck, Abraham S. Kanate, Shahinaz M. Gadalla, David Buchbinder, Manish J. Gandhi, Rammurti T. Kamble, Saurabh Chhabra, Mitchell S. Cairo, Tao Wang, Takanori Teshima, Stephen R. Spellman, Kirk R. Schultz, Hadar A. Frangoul, Vaibhav Agrawal, Taiga Nishihori, Yngvar Fløisand, Amer Beitinjaneh, Michael T. Hemmer, Baldeep Wirk, Pooja Khandelwal, Gerhard C. Hildebrandt, Michael Byrne, Shahrukh K. Hashmi, Ravi Vij, Alvaro Urbano-Ispizua, James Gajewski, Richard F. Olsson, Ayman Saad, Joseph Pidala, Harry C. Schouten, Margaret L. MacMillan, Brian C. Shaffer, Basem M. William, Amin M. Alousi, Edmund K. Waller, David I. Marks, Melhem Solh
Publikováno v:
Biology of Blood and Marrow Transplantation, 25(9), 1875-1883. Elsevier Science
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
Data on whether the T cell dose of allogeneic peripheral blood stem cell (PBSC) products influences transplantation outcomes are conflicting. Using the Center for International Blood and Marrow Transplant Research database, we identified 2736 adult p
Autor:
Yoshihiro Inamoto, Harry C. Schouten, Amin M. Alousi, Ravi Vij, David I. Marks, John E. Wagner, Joseph Pidala, Joseph H. Antin, Margaret L. MacMillan, Gérard Socié, Ayman Saad, Shahrukh K. Hashmi, Luciano J. Costa, Mukta Arora, Hisham Abdel-Azim, Hélène Schoemans, Michael T. Hemmer, Robert Peter Gale, Stephen R. Spellman, Daniel R. Couriel, Saurabh Chhabra, Taiga Nishihori, Sachiko Seo, Alvaro Urbano-Ispizua, Bipin N. Savani, Brenda W. Cooper, Muna Qayed, Robert J. Hayashi, Leo F. Verdonck, Mark R. Litzow, Jean A. Yared, Usama Gergis, Navneet S. Majhail, Betty K. Hamilton, Mahmoud Aljurf, Robert K. Stuart, Rammurti T. Kamble, Leslie Lehmann, Takanori Teshima, Ying Liu, Rodrigo Martino, Jean-Yves Cahn, Olle Ringdén, Peiman Hematti, Melhem Solh, Dennis Dong Hwan Kim
Publikováno v:
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
Dipòsit Digital de la UB
Universidad de Barcelona
Dipòsit Digital de Documents de la UAB
Universitat Autònoma de Barcelona
Biology of Blood and Marrow Transplantation, 25(1), 73-85. Elsevier Science
Recercat: Dipósit de la Recerca de Catalunya
Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya)
Recercat. Dipósit de la Recerca de Catalunya
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
Dipòsit Digital de la UB
Universidad de Barcelona
Dipòsit Digital de Documents de la UAB
Universitat Autònoma de Barcelona
Biology of Blood and Marrow Transplantation, 25(1), 73-85. Elsevier Science
Recercat: Dipósit de la Recerca de Catalunya
Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya)
Recercat. Dipósit de la Recerca de Catalunya
The combination of a calcineurin inhibitor (CNI) such as tacrolimus (TAC) or cyclosporine (CYSP) with methotrexate (MTX) or with mycophenolate mofetil (MMF) has been commonly used for graft-versus-host disease (GVHD) prophylaxis after reduced-intensi
Autor:
Montserrat Rovira, Laura Rosiñol, Nuria Martínez-Cibrian, Alejandra Martínez-Trillos, Francesc Fernández-Avilés, M. A. Marcos, Carolina Garcia-Vidal, Carmen Martínez, Veselka Dimova-Svetoslavova, Beatriz Martín-Antonio, Alvaro Urbano-Ispizua, Gonzalo Gutiérrez-García, Neus Villamor, María Suárez-Lledó
Publikováno v:
Biology of Blood and Marrow Transplantation. 24:2088-2093
This study examined the impact of prednisone (PDN) on cytomegalovirus (CMV) infection after allogeneic stem cell transplantation (allo-SCT) according to donor and recipient CMV serostatus. Seventy-five patients underwent allo-SCT from June 2010 to Ju
Autor:
Alvaro Urbano-Ispizua, Laura Rosiñol, Montserrat Rovira, Ana Sofía Almeida Jorge, María Suárez-Lledó, Carmen Martinez, Gonzalo Gutierrez, Arturo Pereira, Francesc Fernández-Avilés, Noemí Llobet, Teresa Solano
Publikováno v:
Biology of Blood and Marrow Transplantation. 24:1196-1202
The optimal prophylaxis regimen for graft-versus-host disease (GVHD) in the setting of mismatched unrelated donor (MMUD) allogeneic hematopoietic stem cell transplantation (alloHSCT) is not defined. The use of high-dose post-transplant cyclophosphami
Autor:
Andrew St. Martin, Vanderson Rocha, Rizwan Romee, Monzr M. Al Malki, Mei-Jie Zhang, Ran Reshef, Miguel-Angel Perales, Shannon R. McCurdy, Melhem Solh, Maxim Norkin, Ephraim J. Fuchs, Asad Bashey, Mehdi Hamadani, Alvaro Urbano-Ispizua, Daniel A. Keesler, Sameh Gaballa, Edmund K. Waller, Mary Eapen
Publikováno v:
Blood Advances. 2:299-307
We studied the association between non-HLA donor characteristics (age, sex, donor-recipient relationship, blood group [ABO] match, and cytomegalovirus [CMV] serostatus) and transplant outcomes after T-cell-replete HLA-haploidentical transplantation u
Autor:
Alvaro Urbano-Ispizua, Petra Muus, Amanda Wilson, Antonio Almeida, Russell E. Ware, Hubert Schrezenmeier
Publikováno v:
Haematologica, 102, e76-e79
Haematologica, 102, 3, pp. e76-e79
Haematologica, 102, 3, pp. e76-e79
Studies of children with paroxysmal nocturnal hemoglobinuria (PNH) are scarce and include limited numbers of patients. We compared demographic and clinical characteristics of children and adults in the International PNH Registry. Our data show that,
Autor:
María Suárez-Lledó, Alex Bataller, Joan Cid, Carlos Fernández de Larrea, Enric Carreras, Jordi Esteve, María Teresa Cibeira, Joan Bladé, Carmen Martinez, Laura Rosiñol, Julio Solano-Vega, Francesc Fernández-Avilés, María Teresa Solano, Nuria Borràs, Miquel Lozano, Gonzalo Gutiérrez-García, Montserrat Rovira, Pedro Marín, Ariadna Domenech, Natalia Tovar, Luis Gerardo Rodríguez-Lobato, Noemí Llobet, Alvaro Urbano-Ispizua
Publikováno v:
Bone Marrow Transplantation
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
Autologous stem cell transplant (ASCT) has demonstrated to be an effective treatment for patients with light-chain (AL) amyloidosis. However, a high transplant-related mortality (TRM) rate was reported in previous series of patients and questioned th
Autor:
Alvaro Urbano-Ispizua, Hubert Schrezenmeier, Jong Wook Lee, Jin Seok Kim, Austin G. Kulasekararaj, Jun Ho Jang, Louis Terriou, Andrew I. Damokosh, Lori Shafner, Eric Bachman, Anita J. Hill, Rasha Aguzzi, Alexander Röth, Jeff Szer, Scott T. Rottinghaus, Richard A. Wells
Ravulizumab (ALXN1210), a humanized monoclonal antibody to complement component C5, was engineered from eculizumab to have a substantially longer terminal half-life, permitting longer dosing intervals for paroxysmal nocturnal hemoglobinuria (PNH) tre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a63e7b808f134174155d22d0690a91fe
https://europepmc.org/articles/PMC6134221/
https://europepmc.org/articles/PMC6134221/